Matthew Snelson
Overview
Explore the profile of Matthew Snelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biesiekierski J, Yao C, Tuck C, Snelson M
Proc Nutr Soc
. 2024 Nov;
:1-13.
PMID: 39523865
The gastrointestinal (GI) tract plays a critical role in nutrition and the pathophysiology of disease, and there is an increasing variety of methodologies available for the assessment of various aspects...
2.
Snelson M, Deliyanti D, Tan S, Drake A, de Pasquale C, Kumar V, et al.
Nutr Diabetes
. 2024 Jun;
14(1):46.
PMID: 38902253
Background: Dietary-resistant starch is emerging as a potential therapeutic tool to limit the negative effects of diabetes on the kidneys. However, its metabolic and immunomodulatory effects have not yet been...
3.
Tan D, Akelew Y, Snelson M, Nguyen J, OSullivan K
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732038
The gut microbiota and short chain fatty acids (SCFA) have been associated with immune regulation and autoimmune diseases. Autoimmune kidney diseases arise from a loss of tolerance to antigens, often...
4.
Snelson M, Vanuytsel T, Marques F
Curr Hypertens Rep
. 2024 Apr;
26(9):369-380.
PMID: 38662328
Purpose Of The Review: To review what intestinal permeability is and how it is measured, and to summarise the current evidence linking altered intestinal permeability with the development of hypertension....
5.
Jama H, Snelson M, Schutte A, Muir J, Marques F
Hypertension
. 2024 Apr;
81(7):1450-1459.
PMID: 38586958
According to several international, regional, and national guidelines on hypertension, lifestyle interventions are the first-line treatment to lower blood pressure (BP). Although diet is one of the major lifestyle modifications...
6.
R Muralitharan R, Nakai M, Snelson M, Zheng T, Dinakis E, Xie L, et al.
Cardiovasc Res
. 2024 Mar;
120(10):1155-1163.
PMID: 38518247
Aims: Animal models are regularly used to test the role of the gut microbiome in hypertension. Small-scale pre-clinical studies have investigated changes to the gut microbiome in the angiotensin II...
7.
McGuinness A, Stinson L, Snelson M, Loughman A, Stringer A, Hannan A, et al.
Brain Behav Immun
. 2023 Oct;
115:120-130.
PMID: 37806533
Microbiome science has been one of the most exciting and rapidly evolving research fields in the past two decades. Breakthroughs in technologies including DNA sequencing have meant that the trillions...
8.
R Muralitharan R, Snelson M, Meric G, Coughlan M, Marques F
Am J Physiol Renal Physiol
. 2023 Jul;
325(3):F345-F362.
PMID: 37440367
Gut microbiome research has increased dramatically in the last decade, including in renal health and disease. The field is moving from experiments showing mere association to causation using both forward...
9.
de Goes C, Vogt B, Biruete A, Wilkinson T, Snelson M
Front Nutr
. 2023 Feb;
10:1088977.
PMID: 36819692
No abstract available.
10.
Drake A, Coughlan M, Christophersen C, Snelson M
Nutrients
. 2022 Nov;
14(21).
PMID: 36364808
Diabetes is the leading cause of kidney disease, and as the number of individuals with diabetes increases there is a concomitant increase in the prevalence of diabetic kidney disease (DKD)....